GPT Healthcare Ltd

Stage 3 · Topping · week 1

As of 16 Oct 2026, GPT Healthcare is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 12 Oct 2026). It closed at ₹141, 17.4% below its 52-week high and below its 200-day average, which is rising. In Health Care, 40.6% of stocks are in Stage 2.

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. More about the company

₹140.7
+0.68% today
₹1,155 Cr · Small cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is GPTHEALTH early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-17.4%
₹115.3 lo₹170.5 hi
17.4% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-1.4%
200 DMA: ₹142.8 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.56x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -5.4% vs MA50 -2.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-13.8%
3M
-7.7%
6M
+3.6%
YTD
+2.1%
1Y
-4.8%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2024-02-29 → 2026-10-16
S? 42w
S4 29w
S2 17w
2024-02-292026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S3 1w → S2 7w → S3 1w → S4 11w → S1 6w → S4 4w → S1 5w → S2 4w → S3 2w → S4 29w → S1 6w → S2 17w → S3 1w current
Total tracked: 136 weeks across 14 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-25
Pullback Hunter
Latest: 2026-08-14
60 appearances in last 60 days. First seen: 2026-07-03.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S3
Wk 1 · Vol 0.56x
2026-10-15S3
Wk 1 · Vol 0.63x
2026-10-14S3
Wk 1 · Vol 0.36x
2026-10-13S3
Wk 1 · Vol 0.70x
2026-10-12S32→3
Wk 1 · Vol 0.70x
2026-10-09S2
Wk 17 · Vol 0.58x
2026-10-08S2
Wk 17 · Vol 0.99x
2026-10-07S2
Wk 17 · Vol 0.34x
2026-10-06S2
Wk 17 · Vol 0.30x
2026-10-05S2
Wk 16 · Vol 0.39x
2026-10-01S2
Wk 16 · Vol 0.74x
2026-09-30S2
Wk 16 · Vol 0.42x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹154.2
200 DMA
₹142.8
52W High
₹170.5
52W Low
₹115.3
5D Low
₹139.8
Resistance levels (recent highs)
20d High
₹166.2
60d High
₹170.5
120d High
₹170.5
250d High
₹170.5
Next resistance
+18.1%
to 20d High
Ask the Market AI about GPTHEALTHAsk →
P/E (TTM)
27.2
Forward 14.0
Earnings Growth (YoY)
+13.7%
Revenue +24.6%
ROE
+16.3%
Profit margin +8.9%
Dividend Yield
2.16%
P/B 4.5
About this companyHealth Care· Hospitals & Diagnostic Centres

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.